title: Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.
abstract: The melanocortin-4 receptor (MC4R) is a G protein-coupled receptor expressed in the brain, where it controls energy balance through pathways including α-melanocyte-stimulating hormone (α-MSH)-dependent signaling. We have reported that the MC4R can exist in an active conformation that signals constitutively by increasing cAMP levels in the absence of receptor desensitization. We asked whether synthetic MC4R agonists differ in their ability to increase intracellular cAMP over time in Neuro2A cells expressing endogenous MC4R and exogenous, epitope-tagged hemagglutinin-MC4R-green fluorescent protein. By analyzing intracellular cAMP in a temporally resolved Förster resonance energy transfer assay, we show that withdrawal of α-MSH leads to a quick reversal of cAMP induction. By contrast, the synthetic agonist melanotan II (MTII) induces a cAMP signal that persists for at least 1 hour after removal of MTII from the medium and cannot be antagonized by agouti related protein. Similarly, in mHypoE-42 immortalized hypothalamic neurons, MTII, but not α-MSH, induced persistent AMP kinase signal, which occurs downstream of increased cAMP. By using a fluorescence recovery after photobleaching assay, it appears that the receptor exposed to MTII continues to signal after being internalized. Similar to MTII, the synthetic MC4R agonists, THIQ and BIM-22511, but not LY2112688, induced prolonged cAMP signaling after agonist withdrawal. However, agonist-exposed MC4R desensitized to the same extent, regardless of the ligand used and regardless of differences in receptor intracellular retention kinetics. In conclusion, α-MSH and LY2112688, when compared with MTII, THIQ, and BIM-22511, vary in the duration of the acute cAMP response, showing distinct temporal signaling selectivity, possibly linked to specific cell compartments from which cAMP signals may originate.
authors.affiliation: Department of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
authors.forename: Brent M
authors.initials: BM
authors.lastname: Molden
authors.affiliation: Department of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Cooney
authors.affiliation: Department of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
authors.forename: Kirk
authors.initials: K
authors.lastname: West
authors.affiliation: Department of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
authors.forename: Lex H T
authors.initials: LH
authors.lastname: Van Der Ploeg
authors.affiliation: Department of Biochemistry and Molecular Biology (B.M.M., K.A.C., K.W., G.B.), University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205-7199; and Rhythm Pharmaceuticals, Inc (L.H.T.V.D.P.), Boston, Massachusetts 02116.
authors.forename: Giulia
authors.initials: G
authors.lastname: Baldini
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000263:Adenylate Kinase / Q000378:metabolism; D054369:Agouti-Related Protein / Q000494:pharmacology*; D000818:Animals; D002460:Cell Line; D000242:Cyclic AMP / Q000378:metabolism*; D031541:Fluorescence Resonance Energy Transfer; D049452:Green Fluorescent Proteins / Q000235:genetics; D051379:Mice; D010455:Peptides / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology*; D038761:Photobleaching; D011487:Protein Conformation; D044105:Receptor, Melanocortin, Type 4 / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000235:genetics; D044005:Tetrahydroisoquinolines / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology; D000521:alpha-MSH / Q000031:analogs & derivatives* / Q000235:genetics* / Q000494:pharmacology
chemical_list: D054369:Agouti-Related Protein; C579664:LY2112688; C574273:MC4R protein, mouse; C467221:N-(1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl)-1-(4-chlorobenzyl)-2-(4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl)-2-oxoethylamine; D010455:Peptides; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D044005:Tetrahydroisoquinolines; D014230:Triazoles; C079282:melanotan-II; D049452:Green Fluorescent Proteins; D000521:alpha-MSH; D000242:Cyclic AMP; D055372:AMP-Activated Protein Kinases; D000263:Adenylate Kinase